SenesTech Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Joel Fruendt

Chief Executive Officer (CEO)

US$458.3k

Compensación total

Porcentaje del salario del CEO	9.6%
Permanencia del CEO	1.3yrs
Participación del CEO	0.02%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	3.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Joel Fruendt en comparación con los beneficios de SenesTech?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2023	n/a	n/a	-US$8m
Jun 30 2023	n/a	n/a	-US$9m
Mar 31 2023	n/a	n/a	-US$9m
Dec 31 2022	US$458k	US$44k	-US$10m

Compensación vs. Mercado: La compensación total ($USD458.33K) de Joel está en línea con el promedio de empresas de tamaño similar en el mercado German ($USD475.63K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Joel con los resultados de la empresa.

CEO

Joel Fruendt (62 yo)

1.3yrs

Permanencia

US$458,331

Compensación

Mr. Joel L. Fruendt serves as Chief Executive Officer and Director of SenesTech, Inc. since November 15, 2022. He serves as President at SenesTech, Inc. since December 2022. Most recently he served as Pres...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Joel Fruendt	CEO, President & Director	1.3yrs	US$458.33k	0.023% € 1.2k
Anders Field	Advisor	no data	sin datos	sin datos
Matthew Szot	Independent Vice-Chairman of the Board	8.2yrs	US$120.00k	0.00042% € 22.2
Jacob Leach	Independent Director	3.3yrs	US$60.00k	0.013% € 690.7
Julia Williams	Director Emeritus	3.3yrs	US$49.63k	0% € 0
Bill Calloway	Advisor	no data	sin datos	sin datos
Jamie Bechtel	Independent Chairman of the Board & Lead Independent Director	6.1yrs	US$180.70k	0.00025% € 13.2
Delphine Chiavarini	Independent Director	5.7yrs	US$78.50k	0.00013% € 6.9
Phil Grandinetti	Independent Director	3.3yrs	US$76.00k	0% € 0

3.3yrs

Permanencia media

50.5yo

Promedio de edad

Junta con experiencia: La junta directiva de SE81 se considera experimentada (3.3 años de antigüedad promedio).

SenesTech Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

SenesTech, Inc., Annual General Meeting, Jul 11, 2024

Senestech Names Nicole Williams as Chief Revenue Officer

SenesTech, Inc. Announces Executive Changes

SenesTech Announces Resignation of K.C. Kavanagh as Member of Board of Directors

SenesTech, Inc., Annual General Meeting, Jun 23, 2022

High number of new directors

Recent updates

SenesTech Launches Evolve Rodent Birth Control on Walmart Marketplace

SenesTech, Inc. to Report Q3, 2024 Results on Nov 12, 2024

SenesTech, Inc.'s Evolve™ Registers in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution

SenesTech Receives Notification from Nasdaq Due to Non-Compliance with Nasdaq’s Audit Committee Requirements as Set Forth in Nasdaq Listing Rule 5605

SenesTech, Inc. to Report Q2, 2024 Results on Aug 08, 2024

SenesTech, Inc. has filed a Follow-on Equity Offering in the amount of $1.575944 million.

SenesTech, Inc., Annual General Meeting, Jul 11, 2024

SenesTech, Inc. to Report Q1, 2024 Results on May 09, 2024

Nasdaq Determines SenesTech Eligible for an Additional 180 Calendar Day Period, or Until August 19, 2024, to Regain Compliance with the Minimum Bid Price Requirement

SenesTech, Inc. to Report Q4, 2023 Results on Feb 21, 2024

SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve Soft Bait to Open Field Agriculture Applications

SenesTech's ContraPest Registered for Use in Puerto Rico to Combat Rat Infestations

SenesTech, Inc. has completed a Follow-on Equity Offering.

SenesTech, Inc. has completed a Follow-on Equity Offering in the amount of $5 million.

SenesTech Receives a Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

Third quarter 2023 earnings released: US$0.47 loss per share (vs US$4.33 loss in 3Q 2022)

SenesTech, Inc. to Report Q3, 2023 Results on Nov 09, 2023

SenesTech Taking Orders for Evolve™ Soft Bait for Rodent Fertility Control

SenesTech, Inc. Launches Evolve Soft Bait for Rodent Fertility Control

SenesTech Receives Non-Compliance Letter from Nasdaq

Second quarter 2023 earnings released: US$0.70 loss per share (vs US$4.21 loss in 2Q 2022)

SenesTech, Inc. to Report Q2, 2023 Results on Aug 10, 2023

SenesTech, Inc. Launches Isolate Bait System for Contrapest

First quarter 2023 earnings released: US$0.001 loss per share (vs US$3.82 loss in 1Q 2022)

SenesTech, Inc. to Report Q1, 2023 Results on May 11, 2023

No longer forecast to breakeven

Senestech Names Nicole Williams as Chief Revenue Officer

Third quarter 2022 earnings released: US$0.22 loss per share (vs US$0.18 loss in 3Q 2021)

SenesTech, Inc. Announces Executive Changes

SenesTech, Inc. to Report Q3, 2022 Results on Nov 14, 2022

SenesTech Announces Resignation of K.C. Kavanagh as Member of Board of Directors

Second quarter 2022 earnings released: US$0.21 loss per share (vs US$0.14 loss in 2Q 2021)

SenesTech, Inc. to Report Q2, 2022 Results on Aug 11, 2022

SenesTech, Inc. Announces its New Elevate Bait System with ContraPest Now Available in California

SenesTech, Inc. Announces its New Elevate Bait System with ContraPest Available for Sale

First quarter 2022 earnings released: US$0.19 loss per share (vs US$0.22 loss in 1Q 2021)

SenesTech, Inc. to Report Q1, 2022 Results on May 12, 2022

SenesTech, Inc., Annual General Meeting, Jun 23, 2022

Full year 2021 earnings released: US$0.74 loss per share (vs US$2.79 loss in FY 2020)

High number of new directors

Third quarter 2021 earnings released: US$0.18 loss per share (vs US$0.56 loss in 3Q 2020)

Independent Director recently bought €195k worth of stock

Second quarter 2021 earnings released: US$0.14 loss per share (vs US$0.59 loss in 2Q 2020)

Forecast to breakeven in 2025

First quarter 2021 earnings released: US$0.22 loss per share (vs US$1.70 loss in 1Q 2020)

Full year 2020 earnings released: US$2.64 loss per share (vs US$7.69 loss in FY 2019)